Katrina Thornber, Author at European Medical Journal - Page 9 of 50

Combining Vitamin D and Ursodeoxycholic Acid Improves Liver Health in Primary Biliary Cholangitis

Vitamin D boosts UDCA treatment success inpatients with PBC, improving liver function and reducing hepatic fibrosis progression.

Tongue Coating Analysis Offers New Diagnostic Pathway for Parkinson’s Disease

Tongue coating analysis reveals microbial and metabolic markers to aid Parkinson’s disease diagnosis.

Drug-Resistant Bacteria Spread Rapidly in Children with Severe Malnutrition

A new study in Niger reveals a sharp rise in drug-resistant bacteria among hospitalised children treated for severe malnutrition, raising concerns about antibiotic overuse and AMR.

Mental Health Burden Linked to Hidradenitis Suppurativa Severity

Patients with hidradenitis suppurativa face a significantly higher risk of developing new-onset depression and anxiety, according to a large Danish population-based study.

Study Identifies Early Signs of Multiple Sclerosis, 15 Years Before Diagnosis

Health care visits rise years before multiple sclerosis diagnosis, suggesting earlier signs and opportunities for intervention.

Physical Activity Drops Years Before Heart Disease Diagnosis, Study Finds

Adults later diagnosed with cardiovascular disease show declining activity years before onset, highlighting the importance of lifelong exercise.

Ear Acupuncture May Aid Urinary Incontinence Recovery

The researchers suggest that the success of true auriculotherapy may be due to its influence on bladder control mechanisms, possibly via the vagus nerve.

Air Pollution Exposure Linked to Higher Dementia Risk

Long-term exposure to fine particulate matter and nitrogen dioxide is linked to increased dementia risk, according to a major new meta-analysis involving over 24 million people.

No Link Between Aluminium in Vaccines and Autism or ADHD, Landmark Study Finds

Study of over one million children finds no link between aluminium in vaccines and autism or chronic illnesses.

Immunotherapy Combo Shows Promise in Lung Cancer

The BTCRC LUN 16-081 trial is the first to evaluate a shorter, six-month course of consolidation immunotherapy using nivolumab alone or in combination with ipilimumab.